| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Division of Cancer Cell Research, Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo, 108-8639, Japan
Expression of membrane-type (MT) 5 matrix metalloproteinase (MMP) in the mouse brain was examined. MT5-MMP was expressed in the cerebrum in embryos, but it declined after birth. In contrast, expression in the cerebellum started to increase postnatally and continued thereafter. The cells expressing MT5-MMP were postmitotic neurons that showed gelatinolytic activities. Specific expression of MT5-MMP was observed in the neurons but not in the glial cells when embryonal mouse carcinoma P19 cells were differentiated in vitro by retinoic acid treatment. Neurons isolated from dorsal root ganglia also expressed MT5-MMP, and it was localized at the edge of growth cone. Proteoglycans inhibit neurite extension and regulate synaptogenesis. The inhibitory effect of the proteoglycans on neurite extension of dorsal root ganglia neurons was effectively eliminated by recombinant MT5-MMP. Thus, MT5-MMP expressed in neurons may play a role in axonal growth that contributes to the regulation of neural network formation.
This article has been cited by other articles:
![]() |
C. M. Miller, A. Page-McCaw, and H. T. Broihier Matrix metalloproteinases promote motor axon fasciculation in the Drosophila embryo Development, January 1, 2008; 135(1): 95 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahmad, T. Takino, H. Miyamori, T. Yoshizaki, M. Furukawa, and H. Sato Cleavage of Amyloid-{beta} Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases. J. Biochem., March 1, 2006; 139(3): 517 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Monea, B. A. Jordan, S. Srivastava, S. DeSouza, and E. B. Ziff Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci., February 22, 2006; 26(8): 2300 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hehr, J. C. Hocking, and S. McFarlane Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points Development, August 1, 2005; 132(15): 3371 - 3379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, X. Wang, and D. Pei Mint-3 Regulates the Retrieval of the Internalized Membrane-type Matrix Metalloproteinase, MT5-MMP, to the Plasma Membrane by Binding to Its Carboxyl End Motif EWV J. Biol. Chem., May 7, 2004; 279(19): 20461 - 20470. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Larsen, J. E. Wells, W. B. Stallcup, G. Opdenakker, and V. W. Yong Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan J. Neurosci., December 3, 2003; 23(35): 11127 - 11135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Webber, J. C. Hocking, V. W. Yong, C. L. Stange, and S. McFarlane Metalloproteases and Guidance of Retinal Axons in the Developing Visual System J. Neurosci., September 15, 2002; 22(18): 8091 - 8100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |